AXP Underweight: Trim 40-50% into $335-339 rallies, re-engage above $340.74
The Underweight rating is the binding-consistent decision given the alignment of three independent bearish signals—price below 50/100/200 SMA simultaneously, MACD line at -4.04 compressing without confirming reversal, and zero equity risk premium at ~5% earnings yield versus 5% 10Y—combined with an unfavorable risk/reward for fresh shorts at $324.43 (6% risk to $344 stop versus 1.7-4.5% reward targets). Full Sell is prohibited by the 9/10 reflection given 34.4% ROE, $5B+ annual buybacks, and untested lower Bollinger at $320.71 with 52-week low defense intact. The 40-50% trim magnitude (not the 25-30% baseline nor aggressive full-exit) reflects the 9/8/9/9 magnitude calibration yielding approximately +0.3% expected edge over a 5-7 week catalyst window. Q3 2026 earnings credit-cycle risk—net charge-off rates, reserve build, forward guidance—is the linchpin; a clean credit print would force re-evaluation toward Hold.
| Position | Action |
|---|---|
| Post-trim positioning | AXP to 50-60% of benchmark weight |
| Fresh short initiation at $335-339 resistance zone | 25-50% of normal short book sizing |
| Entry at $335-339 trim zone | Target $318.80 (Bollinger lower), $310.00 (March reaction), $290-292 (recession scenario) |
| If credit deterioration materializes | Full exit or move to Sell |
AXP at $324 is a high-quality coiled spring setup where technical momentum exhaustion, accelerating fundamentals (34.4% ROE, 11% EPS growth), and Berkshire's multi-decade endorsement combine for asymmetric upside with 3:1 to 5:1 risk/reward.
| Indicator | Value | Signal |
|---|---|---|
| Close | $324.43 | bearish |
| 10 EMA | $326.45 | bearish |
| 50 SMA | $338.84 | bearish |
| 200 SMA | $335.09 | neutral |
| RSI (14) | 41.39 | neutral |
| MACD | -4.04 | bearish |
| MACD Signal | -3.71 | bearish |
| MACD Histogram | -0.33 | neutral |
| Bollinger Upper | $342.02 | neutral |
| Bollinger Middle | $330.41 | neutral |
| Bollinger Lower | $318.80 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Daily close above $340.74 (falling 50 SMA)
Then: Re-evaluate toward Hold or constructive positioning
AXP's affluent cardholder base provides macro resilience — higher rates are a tailwind, not headwind
EV: +11-13%
AXP is a high-quality business being correctly de-rated in a deteriorating macro environment with rising credit risk lag, hawkish Fed headwinds, multiple compression already underway (down ~16% from $387.49 52-week high), and price below all key moving averages — the timing is wrong even if the fundamentals are sound.
EV: +$3.15 per share (probability-weighted) · concedes: AXP is a great business with strong brand and affluent customer base; Berkshire Hathaway remains a top-3 AXP holder; NII grew 11% YoY and loan book expanded from $208B to $225B; Technical report itself identifies 50 SMA retest at $338.84 as optimal short-entry zone on failed breakout
→ vs conservative: Sitting in cash misses the coiled spring opportunity and fights the tape when institutional positioning is unambiguously bullish with Berkshire anchor
→ vs conservative: Greg Abel succession narrative is a structural re-rating catalyst, not just sentiment; Berkshire's disciplined capital allocation history provides fortress price support
→ vs conservative: PEG ratio of 0.86 in hawkish scenario is selectively pessimistic; buyback-adjusted PEG is well under 1.0 making this a GARP setup
→ vs neutral: Holding and reacting is essentially the same as sitting in cash—both miss the asymmetric entry point at lower Bollinger band
→ vs neutral: Neutral stance fails to price in the compressed volatility setup and momentum exhaustion signals that telegraph breakout
→ vs aggressive: Conservative is intellectually lazy treating Berkshire anchor as mere sentiment rather than structural re-rating catalyst
→ vs conservative: Underweight call leaves most asymmetric opportunity on table; fighting institutional conviction at exactly wrong moment
| neutral |
| ATR | $5.74 | neutral |
| Distance to Lower Band | $5.63 (1.7%) | neutral |
| Distance to Middle Band | $5.98 (1.8%) | neutral |
| Distance to Upper Band | $17.59 (5.4%) | neutral |
| ATR Peak | $9.25 | neutral |
| RSI Peak (July 6, 2026) | 74.57 | bearish |
Support: 318.8 · 310 · 290 · 292 | Resistance: 330.41 · 335.09 · 338.84 · 342.02
AXP is in a late-stage bearish drift within a broader sideways range between March/April 2026 lows near $290 and December 2025 highs near $383, having lost approximately 6.4% from August 4 close of $346.71 to current $324.43. The combination of decelerating downside momentum (MACD histogram compressing from -3.53 to -0.33, ATR compressed from $9.25 to $5.74), price near the lower Bollinger band at $318.80, and RSI at 41.39 not yet reaching oversold conditions creates a setup favoring tactical patience over impulsive action. A confirmed trend reversal requires reclaiming the 50 SMA at $338.84; until then, the FIRST TRANSACTION PROPOSAL recommends HOLD for existing positions while monitoring the $318.80/$310 support zone and MACD histogram for reversal triggers before establishing new positions.
Market Cap
$219.1 B
P/E (TTM)
19.67x
Forward P/E
16.09x
PEG Ratio
1.32
P/B
6.39x
Beta
1.05
52-Week High
$387.49
52-Week Low
$290.97
50-Day Avg
$339.47
200-Day Avg
$336.53
Revenue (TTM)
$70.91 B
Gross Profit
$44.21 B
Operating Margin
20.32%
Profit Margin (Net)
16.14%
ROE
34.38%
ROA
3.79%
EPS (TTM)
$16.49
Forward EPS
$20.16
Diluted EPS Q2 2026
$4.53
Diluted EPS Q1 2026
$4.28
Diluted EPS Q4 2025
$3.53
Diluted EPS Q3 2025
$4.14
Diluted EPS Q2 2025
$4.08
Q2 2026 Revenue
$19,637 M
Q1 2026 Revenue
$18,908 M
Q4 2025 Revenue
$18,981 M
Q3 2025 Revenue
$18,426 M
Q2 2025 Revenue
$17,856 M
Net Interest Income Q2 2026
$4.65 B
Total Assets
$308.2 B
Net Loans
$225.1 B
Cash & Equivalents
$45.2 B
Stockholders' Equity
$34.28 B
Long-Term Debt
$57.0 B
Current Debt
$2.03 B
Debt/Equity (book)
1.72x
Net Debt Q2 2026
$13.88 B
Net Loans Q2 2025
$208.1 B
Net Loans Q4 2025
$220.8 B
FCF Q2 2026
$4.47 B
FCF Q1 2026
$2.66 B
FCF Q4 2025
$2.35 B
FCF Q3 2025
$5.58 B
FCF Q2 2025
$3.75 B
LTM FCF (est.)
~$15.5 B
CapEx Q2 2026
$0.90 B
CapEx Run Rate
~$3 B/yr
Dividends Paid Q2 2026
$0.67 B
Buybacks Q2 2026
$2.30 B
Share Count Q2 2025
696 M
Share Count Q2 2026
682.3 M
Dividend Yield
1.16%
Tax Rate Q2 2026
23.6%
Goodwill
$4.87 B
Net PPE
$7.69 B
Strengths
Concerns
American Express is a high-quality, premium-valued financial with elite profitability (34.38% ROE), accelerating revenue/earnings growth (+10% YoY revenue, +11% YoY EPS), strong free cash flow (~$15.5B annual run rate), and aggressive capital return through buybacks. The current price near the 200-day MA offers a reasonable risk/reward for patient longs, but the premium P/E of 19.7x leaves little margin for error. Bias: Constructive long on weakness; neutral on strength above $350.
Macro: 10Y Treasury surged to a 19-year/2007 high, briefly topping 5%. Prediction markets price 94% probability of zero Fed rate cuts in 2026 (up 0.8pp w/w) with US recession odds jumping to 20% (+12.5pp w/w). Oil holding above $100/barrel with Middle East tensions cited; one print at $105. Fed pricing has migrated from cut-pricing to hike-pricing. Inflation described as 'sticky.' Equities lower on the week as yields climbed; chip stocks sold off on AI warning.